Function Acquires Getlabs, Bringing AI-Driven Health Testing to Your Doorstep

AUSTIN, Texas – April 08, 2026 – In a significant move to reshape the landscape of personal health management, health data company Function today announced its acquisition of Getlabs, a leading platform for mobile diagnostic services. The deal promises to bring licensed medical specialists directly to the homes and offices of Function members, marking a pivotal step in the company's mission to make comprehensive health data more accessible than ever.

For the first time, many of Function's rapidly growing member base will have the option to bypass a trip to a lab facility. Instead, they can schedule a visit from a Getlabs specialist for blood draws and other services at a location of their choosing. This integration directly tackles some of the most persistent barriers to proactive healthcare: the inconvenience of travel, rigid scheduling, and mobility challenges that cause many to delay or skip crucial diagnostic tests.

The New Era of Convenience in Health Monitoring

The core of the acquisition is a fundamental shift in the user experience. Function members, who pay an annual fee for access to over 160 biannual lab tests, have traditionally visited one of more than 2,000 Quest Diagnostics locations for their blood draws. Now, they will be presented with a choice: visit a lab or have the lab come to them.

Function emphasizes that the underlying service—the comprehensive lab panels, the intelligent results platform, and the clinical guidance—will remain identical regardless of the collection method. The only difference is who travels. This move is powered by Getlabs' sophisticated logistics, which includes AI-assisted routing designed to streamline the scheduling process and increase the reliability of on-time visits.

"Your zip code, your schedule, and your life circumstances shouldn't determine what health information you have access to," said Jonathan Swerdlin, CEO and co-founder of Function, in the announcement. "Bringing testing directly to people isn't just convenience – it's access. Function is on a mission to enable 8 billion people to live 100 healthy years, and that is only possible when you scale the ability to make health data accessible to wherever people are."

Getlabs' existing nationwide network of providers and health system partners will continue its operations uninterrupted, now bolstered by the resources of the fast-growing health tech platform.

A Strategic Move in a Competitive Wellness Market

This acquisition is a calculated maneuver in the fiercely competitive direct-to-consumer (DTC) health and wellness sector. Function, which launched its beta in 2023, has experienced meteoric growth, amassing over 100,000 paying members by the end of 2024 and securing a staggering $2.5 billion valuation by early 2025. The company competes with established players like InsideTracker and Everlywell by offering one of the most comprehensive sets of biomarkers available directly to consumers for a single annual fee.

The purchase of Getlabs is the latest in a series of strategic expansions for Function. In late 2025, the company acquired Ezra, an advanced imaging company, to integrate FDA-cleared, AI-enhanced MRI and CT scans into its offerings. By adding Getlabs' mobile phlebotomy network, Function solidifies its position as an end-to-end solution for proactive health. It directly addresses a key logistical hurdle that all data-first health companies face: the physical collection of biological samples. This integration provides a significant competitive advantage, creating a more seamless and attractive service for both new and existing members.

The move allows Function to control a larger portion of the customer journey, from scheduling and sample collection to data analysis and insight delivery, reducing reliance on third-party clinic infrastructure and improving the overall user experience.

Powering Proactive Health with AI and Longitudinal Data

At its core, Function's vision extends beyond simple lab testing. The company aims to transform episodic health checks into a continuous stream of longitudinal data, which can then be analyzed by its proprietary AI engine, the Medical Intelligence Lab™ (MI Lab™). Launched in late 2025, the MI Lab integrates data from lab tests, imaging, wearables, and medical records to identify health trends and early warning signals that might otherwise be missed.

The acquisition of Getlabs is critical to fueling this data-centric model. By making blood draws radically convenient, Function can encourage the regular, biannual testing included in its membership, ensuring a consistent flow of data points over a member's lifetime. This rich, continuous dataset is the raw material the MI Lab uses to generate personalized insights, from identifying hidden inflammation and metabolic issues to tracking nutrient levels and hormone balance over time.

"At Getlabs, we believe access to testing is a fundamental piece to owning your health," stated Claire Hough, CEO of Getlabs. "Together with Function, we can make testing more accessible and seamless, reaching more of the phlebotomists, care teams, and providers who make that possible every day. That mission doesn't change. It scales." This scaling of physical infrastructure is essential for realizing the promise of AI-managed lifelong health, bridging the gap between software-based insights and real-world biology.

Navigating Health Equity and a Complex Regulatory Path

Beyond the business strategy and technological innovation, the acquisition carries significant implications for health equity. By bringing services to the user, Function and Getlabs can better serve populations that face barriers to traditional healthcare, including the elderly, individuals with disabilities, rural residents with limited access to clinics, and busy caregivers. This model helps democratize access to the kind of in-depth health data that has often been the domain of the privileged and proactive.

However, operating at this intersection of mobile health, DTC testing, and big data requires careful navigation of a complex regulatory environment. All testing is processed by CLIA and CAP-certified labs like Quest Diagnostics to ensure clinical accuracy. Furthermore, as a handler of vast amounts of sensitive personal health information (PHI), Function must adhere to stringent HIPAA standards for data privacy and security. The company's AI-driven platform, which synthesizes lab results with uploaded medical records and wearable data, places an immense responsibility on it to protect user privacy and ensure informed consent.

As the lines between consumer technology and clinical healthcare continue to blur, this acquisition highlights a powerful trend: the decentralization of care. By combining Getlabs' physical, on-the-ground network with its own sophisticated data analytics platform, Function is betting that the future of health isn't just about what happens in a doctor's office, but about creating an intelligent, accessible, and continuous health loop that begins and ends in the home.